cherry silverberry

Elaeagnus multiflora

Elaeagnus multiflora is a plant native to East Asia, particularly in China and Japan, where it has been traditionally used for various purposes. While specific traditional uses are not well-documented, studies have shown that extracts from this plant may have potential benefits for men with lower urinary tract symptoms (LUTS). A study comparing E. multiflora with a placebo found that it significantly reduced International Prostate Symptom Score (IPSS) by 4.67 points more than the placebo in men with moderate LUTS after 12 weeks, though the evidence is limited and further research is needed to confirm these findings. The plant contains various bioactive compounds, including polyphenols and isoprenoids, which may contribute to its potential nutritional and medicinal uses. No major safety concerns or drug interactions have been reported for E. multiflora, but as with any herbal supplement, it is advisable to consult a healthcare provider before use.

At a glance
Best evidence
D
Cautions

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.

What the science says

  • The E. multiflora and C. wilfordii complex significantly reduced total IPSS by 4.67 points more than placebo in men with moderate LUTS after 12 weeks. D PMID
  • The cherry silverberry contains various bioactive compounds and has potential nutritional and medicinal uses. D PMID
  • The study compared sediment and pomace from three Elaeagnus multiflora cultivars, identifying variations in bioactive compounds and minerals. D PMID
  • The study identified significant differences in polyphenolic and isoprenoid compound profiles among the fruit skin + pulp, seeds, and leaves of six Elaeagnus multiflora Thunb. biotypes. D PMID

Frequently asked questions

What is cherry silverberry?

cherry silverberry (Elaeagnus multiflora) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about cherry silverberry?

4 sourced findings are recorded for cherry silverberry; the strongest carries evidence grade D. For example: The E. multiflora and C. wilfordii complex significantly reduced total IPSS by 4.67 points more than placebo in men with moderate LUTS after 12 weeks.

How strong is the evidence for cherry silverberry?

The strongest finding for cherry silverberry carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is cherry silverberry safe? What are the side effects?

No major safety issues are recorded for cherry silverberry in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does cherry silverberry interact with medications?

No drug interactions are recorded for cherry silverberry in our sources. This does not rule them out — check with a pharmacist.

What are the common names of cherry silverberry?

cherry silverberry is also known as: Лох многоцветковый, Goumi du Japon.

Is cherry silverberry a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Sources

  1. T2 Distribution of Polyphenolic and Isoprenoid Compounds and Biological Activity Differences between in the Fruit Skin + Pulp, Seeds, and Leaves of New Biotypes of Elaeagnusmultiflora Thunb. literature abstract metadata
  2. T2 The Bioactive Profile, Nutritional Value, Health Benefits and Agronomic Requirements of Cherry Silverberry (Elaeagnus multiflora Thunb.): A Review. literature abstract metadata
  3. T2 Efficacy of Elaeagnus multiflora and Cynanchum wilfordii Complex Extract on Male Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. literature abstract metadata
  4. T2 Phytochemical and bioactivities comparison of three cultivars of goumi (Elaeagnus multiflora Thunb.) berry juice sediments and pomace: a waste valorisation perspective. literature abstract metadata